The knockdown of CPT1C inhibited the tumorigenesis of PANC-1 cells in vivo [2, 33] and further suppressed xenograft tumor growth in situ [2], suggesting that CPT1C represents a therapeutic target for cancer treatment. Here, CPT1C is linked to neoplasm.